These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 38212487)

  • 1. Increased cardiovascular risk in Korean patients with systemic lupus erythematosus: a population-based cohort study.
    Han JY; Cho SK; Kim H; Jeon Y; Kang G; Jung SY; Jang EJ; Sung YK
    Sci Rep; 2024 Jan; 14(1):1082. PubMed ID: 38212487
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts.
    Almaghlouth I; Bohuliga KG; Alanazi B; Alhawsa BK; Alabdulkareem AM; Alqarawi W; Asfina KN; Khalil N; Ali HH; Bedaiwi M; Aboabat A; Su J; Alam TA; Alanazi FG; Omair MA; Alarfaj AS; Almalag HM; Al Shamiri M; Alhabib KF
    Lupus Sci Med; 2024 May; 11(1):. PubMed ID: 38789277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic lupus erythematosus and the risk of perioperative major adverse cardiovascular events.
    Smilowitz NR; Katz G; Buyon JP; Clancy RM; Berger JS
    J Thromb Thrombolysis; 2018 Jan; 45(1):13-17. PubMed ID: 29230625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of end-stage renal disease in systemic lupus erythematosus: A nationwide population-based study in Korea.
    Choi HS; Han KD; Jung JH; Kim CS; Bae EH; Ma SK; Kim SW
    Medicine (Baltimore); 2019 Jul; 98(28):e16420. PubMed ID: 31305460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic lupus erythematosus is a risk factor for cardiovascular disease: a nationwide, population-based study in Korea.
    Lim SY; Bae EH; Han KD; Jung JH; Choi HS; Kim HY; Kim CS; Ma SK; Kim SW
    Lupus; 2018 Nov; 27(13):2050-2056. PubMed ID: 30282562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing cardiovascular risk prediction for patients with systemic lupus erythematosus.
    Choi MY; Guan H; Yoshida K; Paudel M; Kargere BA; Li D; Ellrodt J; Stevens E; Cai T; Weber BN; Everett BM; Costenbader KH
    Semin Arthritis Rheum; 2024 Aug; 67():152468. PubMed ID: 38788567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Myocardial Infarction and Stroke in Newly Diagnosed Systemic Lupus Erythematosus: A General Population-Based Study.
    Aviña-Zubieta JA; To F; Vostretsova K; De Vera M; Sayre EC; Esdaile JM
    Arthritis Care Res (Hoboken); 2017 Jun; 69(6):849-856. PubMed ID: 28129475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence and risk factors of osteomyelitis in adult and pediatric systemic lupus erythematosus: a nationwide, population-based cohort study.
    Huang YF; Chang YS; Chen WS; Tsao YP; Wang WH; Liao HT; Tsai CY; Lai CC
    Lupus; 2019 Jan; 28(1):19-26. PubMed ID: 30458691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered Risk for Cardiovascular Events With Changes in the Metabolic Syndrome Status: A Nationwide Population-Based Study of Approximately 10 Million Persons.
    Park S; Lee S; Kim Y; Lee Y; Kang MW; Han K; Han SS; Lee H; Lee JP; Joo KW; Lim CS; Kim YS; Kim DK
    Ann Intern Med; 2019 Dec; 171(12):875-884. PubMed ID: 31766057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of malignancy in patients with systemic lupus erythematosus: population-based cohort study in Korea.
    Han JY; Kim H; Jung SY; Jang EJ; Cho SK; Sung YK
    Arthritis Res Ther; 2021 Oct; 23(1):270. PubMed ID: 34706772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology and risk of invasive fungal infections in systemic lupus erythematosus: a nationwide population-based cohort study.
    Su CF; Lai CC; Li TH; Chang YF; Lin YT; Chen WS; Tsao YP; Wang WH; Chang YS; Tsai CY
    Ther Adv Musculoskelet Dis; 2021; 13():1759720X211058502. PubMed ID: 34840609
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence, incidence, and associated factors of avascular necrosis in Korean patients with systemic lupus erythematosus: a nationwide epidemiologic study.
    Joo YB; Sung YK; Shim JS; Kim JH; Lee EK; Lee HS; Bae SC
    Rheumatol Int; 2015 May; 35(5):879-86. PubMed ID: 25300729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks of ophthalmic disorders in patients with systemic lupus erythematosus - a secondary cohort analysis of population-based claims data.
    Hsu CS; Hsu CW; Lu MC; Koo M
    BMC Ophthalmol; 2020 Mar; 20(1):96. PubMed ID: 32160869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and prevalence of systemic lupus erythematosus among Korean women in childbearing years: A nationwide population-based study.
    Chung MK; Park JS; Lim H; Lee CH; Lee J
    Lupus; 2021 Apr; 30(4):674-679. PubMed ID: 33460342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure risk in systemic lupus erythematosus compared to diabetes mellitus and general medicaid patients.
    Chen SK; Barbhaiya M; Fischer MA; Guan H; Yoshida K; Feldman CH; Costenbader KH; Everett BM
    Semin Arthritis Rheum; 2019 Dec; 49(3):389-395. PubMed ID: 31280938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular events and risk in patients with systemic lupus erythematosus: Systematic literature review and meta-analysis.
    Bello N; Meyers KJ; Workman J; Hartley L; McMahon M
    Lupus; 2023 Mar; 32(3):325-341. PubMed ID: 36547368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pregnancy rates and perinatal outcomes in women with systemic lupus erythematosus: data from the Korean national health claims database.
    Joo YB; Kim KJ; Park KS; Park YJ
    Clin Rheumatol; 2021 Jun; 40(6):2243-2250. PubMed ID: 33184707
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and risk factors for osteoporotic fractures in patients with systemic lupus erythematosus versus matched controls.
    Kim CS; Han KD; Jung JH; Choi HS; Bae EH; Ma SK; Kim SW
    Korean J Intern Med; 2021 Jan; 36(1):154-163. PubMed ID: 31234614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of hydroxychloroquine and risk of major adverse cardiovascular events in patients with lupus erythematosus: A Danish nationwide cohort study.
    Haugaard JH; Dreyer L; Ottosen MB; Gislason G; Kofoed K; Egeberg A
    J Am Acad Dermatol; 2021 Apr; 84(4):930-937. PubMed ID: 33321159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-Term Cardiovascular Outcomes in Systemic Lupus Erythematosus.
    Yafasova A; Fosbøl EL; Schou M; Baslund B; Faurschou M; Docherty KF; Jhund PS; McMurray JJV; Sun G; Kristensen SL; Torp-Pedersen C; Køber L; Butt JH
    J Am Coll Cardiol; 2021 Apr; 77(14):1717-1727. PubMed ID: 33832598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.